Putting the award page together from the records…
Putting the award page together from the records…
LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT
Up for re-bid: ends 2027-09-29. Recompete brief → · J&A to extend Period or Performance for procurement of Inmazeb ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
2 orders worth $3.82M (current value). The largest:
1 action since 2023-11-02. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2023-11-02 | P00001 | Change order | $0 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗